This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1224)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Topic Collections  • Quality of Care  • Evidence-Based Medicine  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

A Meta-analysis of Prospective Studies

Jason Lazarou, MSc; Bruce H. Pomeranz, MD, PhD; Paul N. Corey, PhD

JAMA. 1998;279:1200-1205.

Objective.— To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients.

Data Sources.— Four electronic databases were searched from 1966 to 1996.

Study Selection.— Of 153, we selected 39 prospective studies from US hospitals.

Data Extraction.— Data extracted independently by 2 investigators were analyzed by a random-effects model. To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death.

Data Synthesis.— The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2216000 (1721000-2711000) hospitalized patients had serious ADRs and 106000 (76000-137000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death.

Conclusions.— The incidence of serious and fatal ADRs in US hospitals was found to be extremely high. While our results must be viewed with circumspection because of heterogeneity among studies and small biases in the samples, these data nevertheless suggest that ADRs represent an important clinical issue.

From the Departments of Zoology (Mr Lazarou and Dr Pomeranz), Physiology (Dr Pomeranz), and Public Health Sciences (Dr Corey), University of Toronto, Toronto, Ontario.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Adverse Drug Reactions in Hospitalized Patients
Kenneth Fremont-Smith, Gary R. Kravitz, Tom Bush, Randy Hanzlick, Peter B. Baker, Grover M. Hutchins, Ka-Kit Hui, Jason Lazarou, Bruce H. Pomeranz, Paul N. Corey, and David W. Bates
JAMA. 1998;280(20):1741.
EXTRACT | FULL TEXT  

Time for Action on Drug Safety
Greg A. Burkhart, Deborah Shatin, Jacqueline S. Gardner, Andy Stergachis, James J. Rybacki, Thomas J. Moore, Bruce M. Psaty, and Curt D. Furberg
JAMA. 1999;281(4):319-322.
EXTRACT | FULL TEXT  

Deficiencies in US Medical Care
Jerome A. Collins, Yasuo Ishida, James Long, J. Louis Pecora, Bradley L. White, Jonathan D. Reich, and Barbara Starfield
JAMA. 2000;284(17):2184-2185.
EXTRACT | FULL TEXT  

Formal Education About Medication Errors in Internal Medicine Clerkships
Curtis J. Rosebraugh, Peter K. Honig, Sally Usdin Yasuda, John C. Pezzullo, David A. Flockhart, and Raymond L. Woosley
JAMA. 2001;286(9):1019-1020.
EXTRACT | FULL TEXT  

RELATED ARTICLES

The Role of Alcohol and Social Stress in Russia's Mortality Rate
Vasiliy Vlassov, Francis C. Notzon, Yuri M. Komarov, Sergei P. Ermakov, Christopher T. Sempos, James S. Marks, Elena V. Sempos, David A. Leon, and Vladimir M. Shkolnikov
JAMA. 1999;281(4):321.
EXTRACT | FULL TEXT  

Drugs and Adverse Drug Reactions: How Worried Should We Be?
David W. Bates
JAMA. 1998;279(15):1216-1217.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis, management and prevention of drug-induced liver injury
Verma and Kaplowitz
Gut 2009;58:1555-1564.
ABSTRACT | FULL TEXT  

A Combined-Cross Analysis Reveals Genes With Drug-Specific and Background-Dependent Effects on Drug Sensitivity in Saccharomyces cerevisiae
Kim and Fay
Genetics 2009;183:1141-1151.
ABSTRACT | FULL TEXT  

Commentary: Motes, beams and evidence-based practice
Fisher and Katz
J Health Serv Res Policy 2009;14:224-225.
FULL TEXT  

Interventions to Improve Medication Reconciliation in Primary Care
Bayoumi et al.
The Annals of Pharmacotherapy 2009;43:1667-1675.
ABSTRACT | FULL TEXT  

Pediatric Adverse Drug Events in the Outpatient Setting: An 11-Year National Analysis
Bourgeois et al.
Pediatrics 2009;124:e744-e750.
ABSTRACT | FULL TEXT  

Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models
Deng et al.
Pharmacol. Rev. 2009;61:262-282.
ABSTRACT | FULL TEXT  

Adverse drug reactions in childhood: a review of prospective studies and safety alerts
Clavenna and Bonati
Arch. Dis. Child. 2009;94:724-728.
ABSTRACT | FULL TEXT  

Development of a Fluorescence-Based, Ultra High-Throughput Screening Platform for Nanoliter-Scale Cytochrome P450 Microarrays
Sukumaran et al.
J Biomol Screen 2009;14:668-678.
ABSTRACT  

Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007
Vassilev et al.
Am J Health Syst Pharm 2009;66:481-487.
ABSTRACT | FULL TEXT  

Analytic Reviews: Considerations in Caring for the Critically Ill Older Patient
Pisani
J Intensive Care Med 2009;24:83-95.
ABSTRACT  

Promoting More Conservative Prescribing
Schiff and Galanter
JAMA 2009;301:865-867.
FULL TEXT  

Assessment of potential drug interactions in patients with epilepsy: Impact of age and sex
Gidal et al.
Neurology 2009;72:419-425.
ABSTRACT | FULL TEXT  

Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study
Zhang et al.
BMJ 2009;338:a2752-a2752.
ABSTRACT | FULL TEXT  

Readmissions as a result of adverse drug reactions in older people
Morgan
BMJ 2009;338:a2436-a2436.
FULL TEXT  

The Role of Haptic Macrophages in Regulation of Idiosyncratic Drug Reactions
Ju
Toxicol Pathol 2009;37:12-17.
ABSTRACT | FULL TEXT  

Evaluation of a computer-based adverse-drug-event monitor
Hwang et al.
Am J Health Syst Pharm 2008;65:2265-2272.
ABSTRACT | FULL TEXT  

Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury
Holt et al.
J. Leukoc. Biol. 2008;84:1410-1421.
ABSTRACT | FULL TEXT  

Metabolic Activity of Cytochrome P450 Isoforms in Hepatocytes Cryopreserved with Wheat Protein Extract
Grondin et al.
Drug Metab. Dispos. 2008;36:2121-2129.
ABSTRACT | FULL TEXT  

Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands
Leendertse et al.
Arch Intern Med 2008;168:1890-1896.
ABSTRACT | FULL TEXT  

Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application
Jha et al.
J. Am. Med. Inform. Assoc. 2008;15:647-653.
ABSTRACT | FULL TEXT  

Pharmacogenomics and Drug Toxicity
Nakamura
NEJM 2008;359:856-858.
FULL TEXT  

Functional Consequences of Active Hepatic Uptake on Cytochrome P450 Inhibition in Rat and Human Hepatocytes
Grime et al.
Drug Metab. Dispos. 2008;36:1670-1678.
ABSTRACT | FULL TEXT  

A Randomized Trial of the Effectiveness of On-demand versus Computer-triggered Drug Decision Support in Primary Care
Tamblyn et al.
J. Am. Med. Inform. Assoc. 2008;15:430-438.
ABSTRACT | FULL TEXT  

Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies
Kongkaew et al.
The Annals of Pharmacotherapy 2008;42:1017-1025.
ABSTRACT | FULL TEXT  

Identification of suspected fatal adverse drug reactions by paediatricians: a UK surveillance study
Cheng et al.
Arch. Dis. Child. 2008;93:609-611.
ABSTRACT | FULL TEXT  

Adverse-drug-reaction reporting by pharmacy students in a teaching hospital
Sullivan and Spooner
Am J Health Syst Pharm 2008;65:1177-1179.
ABSTRACT | FULL TEXT  

Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study
Zed et al.
CMAJ 2008;178:1563-1569.
ABSTRACT | FULL TEXT  

Evaluation of Fluorescence- and Mass Spectrometry--Based CYP Inhibition Assays for Use in Drug Discovery
Bell et al.
J Biomol Screen 2008;13:343-353.
ABSTRACT  

An Examination of Factors Related To Radiation Protection Practices
SLECHTA and REAGAN
radtech 2008;79:297-305.
ABSTRACT | FULL TEXT  

Turning the gene tap off; implications of regulating gene expression for cancer therapeutics
Curtin et al.
Molecular Cancer Therapeutics 2008;7:439-448.
ABSTRACT | FULL TEXT  

Inappropriate prescribing in the older population: need for new criteria
O'Mahony and Gallagher
Age Ageing 2008;37:138-141.
ABSTRACT | FULL TEXT  

Nationwide Survey of Subjectively Reported Adverse Drug Reactions in Sweden
Isacson et al.
The Annals of Pharmacotherapy 2008;42:347-353.
ABSTRACT | FULL TEXT  

Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria
Gallagher et al.
Age Ageing 2008;37:96-101.
ABSTRACT | FULL TEXT  

Impact of Computerized Prescriber Order Entry on the Incidence of Adverse Drug Events in Pediatric Inpatients
Holdsworth et al.
Pediatrics 2007;120:1058-1066.
ABSTRACT | FULL TEXT  

Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer
Sauna et al.
Cancer Res. 2007;67:9609-9612.
ABSTRACT | FULL TEXT  

Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005
Moore et al.
Arch Intern Med 2007;167:1752-1759.
ABSTRACT | FULL TEXT  

Admissions to a medical intensive care unit related to adverse drug reactions
Rivkin
Am J Health Syst Pharm 2007;64:1840-1843.
ABSTRACT | FULL TEXT  

Potential drug-drug interactions within Veterans Affairs medical centers
Mahmood et al.
Am J Health Syst Pharm 2007;64:1500-1505.
ABSTRACT | FULL TEXT  

Evaluation of Outpatient Computerized Physician Medication Order Entry Systems: A Systematic Review
Eslami et al.
J. Am. Med. Inform. Assoc. 2007;14:400-406.
ABSTRACT | FULL TEXT  

The Utility of Adding Retrospective Medication Profiling to Computerized Provider Order Entry in an Ambulatory Care Population
Glassman et al.
J. Am. Med. Inform. Assoc. 2007;14:424-431.
ABSTRACT | FULL TEXT  

A Systematic Review of the Performance Characteristics of Clinical Event Monitor Signals Used to Detect Adverse Drug Events in the Hospital Setting
Handler et al.
J. Am. Med. Inform. Assoc. 2007;14:451-458.
ABSTRACT | FULL TEXT  

ASHP Long-Range Vision for the Pharmacy Work Force in Hospitals and Health Systems: Ensuring the Best Use of Medicines in Hospitals and Health Systems
Am J Health Syst Pharm 2007;64:1320-1330.
FULL TEXT  

Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers
Bennett et al.
Arch Intern Med 2007;167:1041-1049.
ABSTRACT | FULL TEXT  

The role of communication in paediatric drug safety
Stebbing et al.
Arch. Dis. Child. 2007;92:440-445.
ABSTRACT | FULL TEXT  

Drug-Induced Sweet's Syndrome
Thompson and Montarella
The Annals of Pharmacotherapy 2007;41:802-811.
ABSTRACT | FULL TEXT  

Managing Complex Medication Regimens: Perspectives of Consumers with Osteoarthritis and Healthcare Professionals
Manias et al.
The Annals of Pharmacotherapy 2007;41:764-771.
ABSTRACT | FULL TEXT  

Pharmacists versus nonpharmacists in adverse drug event detection: A meta-analysis and systematic review
Phansalkar et al.
Am J Health Syst Pharm 2007;64:842-849.
ABSTRACT | FULL TEXT  

Multidisciplinary approach to inpatient medication reconciliation in an academic setting
Varkey et al.
Am J Health Syst Pharm 2007;64:850-854.
ABSTRACT | FULL TEXT  

An ounce of prevention: A pound of cure for an ailing health care system
Genuis
cfp 2007;53:597-599.
FULL TEXT  

Une once de prevention: Prescription pour un systeme de sante en dif_culte
Genuis
cfp 2007;53:605-607.
FULL TEXT  

Pharmaceutical Care in Community Pharmacies: Practice and Research in Denmark
Herborg et al.
The Annals of Pharmacotherapy 2007;41:681-689.
ABSTRACT | FULL TEXT  

Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Roberts et al.
Toxicol Sci 2007;96:2-15.
ABSTRACT | FULL TEXT  

The in Vitro Drug Interaction Potential of Dietary Supplements Containing Multiple Herbal Components
Foti et al.
Drug Metab. Dispos. 2007;35:185-188.
ABSTRACT | FULL TEXT  

The Pregnane X Receptor Gene-Humanized Mouse: A Model for Investigating Drug-Drug Interactions Mediated by Cytochromes P450 3A
Ma et al.
Drug Metab. Dispos. 2007;35:194-200.
ABSTRACT | FULL TEXT  

Escalating polypharmacy
Gorard
QJM 2006;99:797-800.
ABSTRACT | FULL TEXT  

The FDA and drug safety: a proposal for sweeping changes.
Furberg et al.
Arch Intern Med 2006;166:1938-1942.
ABSTRACT | FULL TEXT  

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
Hassett et al.
JNCI J Natl Cancer Inst 2006;98:1108-1117.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions Among Children Over a 10-Year Period
Le et al.
Pediatrics 2006;118:555-562.
ABSTRACT | FULL TEXT  

Genetic testing in cancer therapeutics.
Ezzeldin and Diasio
Clin. Cancer Res. 2006;12:4137-4141.
FULL TEXT  

Enhanced Xenobiotic-Induced Hepatotoxicity and Kupffer Cell Activation by Restraint-Induced Stress
Panuganti et al.
J. Pharmacol. Exp. Ther. 2006;318:26-34.
ABSTRACT | FULL TEXT  

Metabolism of Efavirenz and 8-Hydroxyefavirenz by P450 2B6 Leads to Inactivation by Two Distinct Mechanisms
Bumpus et al.
J. Pharmacol. Exp. Ther. 2006;318:345-351.
ABSTRACT | FULL TEXT  

Drug Dosage Adjustments According to Renal Function at Hospital Discharge
van Dijk et al.
The Annals of Pharmacotherapy 2006;40:1254-1260.
ABSTRACT | FULL TEXT  

Adverse Drug Event Reporting in Intensive Care Units: A Survey of Current Practices
Kane-Gill and Devlin
The Annals of Pharmacotherapy 2006;40:1267-1273.
ABSTRACT | FULL TEXT  

Effect of internal reporting criteria on suspected adverse drug reactions submitted to MedWatch
Smith et al.
Am J Health Syst Pharm 2006;63:949-952.
FULL TEXT  

Pharmacogenomics: from bedside to clinical practice.
Marsh and McLeod
Hum Mol Genet 2006;15:R89-R93.
ABSTRACT | FULL TEXT  

The Development and Evaluation of an Integrated Electronic Prescribing and Drug Management System for Primary Care
Tamblyn et al.
J. Am. Med. Inform. Assoc. 2006;13:148-159.
ABSTRACT | FULL TEXT  

Adherence to black box warnings for prescription medications in outpatients.
Lasser et al.
Arch Intern Med 2006;166:338-344.
ABSTRACT | FULL TEXT  

Antibiotic Allergy
Gruchalla and Pirmohamed
NEJM 2006;354:601-609.
FULL TEXT  

Where now for pharmacist led medication review?
Holland et al.
J. Epidemiol. Community Health 2006;60:92-93.
FULL TEXT  

Improving the accuracy of patient identification in the medication-use process
Trapskin et al.
Am J Health Syst Pharm 2006;63:218-222.
FULL TEXT  

Suboptimal Medication Use and Mortality in an Older Adult Community-Based Cohort: Results From the Hispanic EPESE Study.
Espino et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006;61:170-175.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions in a Department of Pediatric Surgery
Farrokhi et al.
J Trop Pediatr 2006;52:72-73.
FULL TEXT  

Relationship of Medication Use to Health-Related Quality of Life Among a Group of Older American Indians
Henderson et al.
Journal of Applied Gerontology 2006;25:89S-104S.
ABSTRACT  

Interethnic Differences in Genetic Polymorphisms of CYP2D6 in the U.S. Population: Clinical Implications.
Bernard et al.
The Oncologist 2006;11:126-135.
ABSTRACT | FULL TEXT  

Racializing Drug Design: Implications of Pharmacogenomics for Health Disparities
Lee
AJPH 2005;95:2133-2138.
ABSTRACT | FULL TEXT  

AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS
Atkinson et al.
Drug Metab. Dispos. 2005;33:1637-1647.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions in Hospitalized Children in a Department of Infectious Diseases
Fattahi et al.
J Clin Pharmacol 2005;45:1313-1318.
FULL TEXT  

Identification of Inappropriate Drug Prescribing by Computerized, Retrospective DUR Screening in Korea
Yeom et al.
The Annals of Pharmacotherapy 2005;39:1918-1923.
ABSTRACT | FULL TEXT  

Pharmacogenetics/genomics and personalized medicine
Sadee and Dai
Hum Mol Genet 2005;14:R207-R214.
ABSTRACT | FULL TEXT  

Drug-Related Visits to the Emergency Department
Zed
Journal of Pharmacy Practice 2005;18:329-335.
ABSTRACT  

Genomic medicine: genetic variation and its impact on the future of health care
Willard et al.
Phil Trans R Soc B 2005;360:1543-1550.
ABSTRACT | FULL TEXT  

Pharmacogenetics in drug development
McCarthy et al.
Phil Trans R Soc B 2005;360:1579-1588.
ABSTRACT | FULL TEXT  

Adverse Drug Reactions and Avalanches: Life at the Edge of Chaos
Frattarelli
J Clin Pharmacol 2005;45:866-871.
ABSTRACT | FULL TEXT  

The Efficacy and Safety of Pain Management Before and After Implementation of Hospital-Wide Pain Management Standards: Is Patient Safety Compromised by Treatment Based Solely on Numerical Pain Ratings?
Vila et al.
Anesth. Analg. 2005;101:474-480.
ABSTRACT | FULL TEXT  

Accuracy of adverse-drug-event reports collected using an automated dispensing system
Romero and Malone
Am J Health Syst Pharm 2005;62:1375-1380.
ABSTRACT | FULL TEXT  

Epidemiology, Comparative Methods of Detection, and Preventability of Adverse Drug Events
Al-Tajir and Kelly
The Annals of Pharmacotherapy 2005;39:1169-1174.
ABSTRACT | FULL TEXT  

Pharmacogenomics: Harbinger for the Era of Personalized Medicine?
Sadee
Mol. Interv. 2005;5:140-143.
FULL TEXT  

Challenging times for food allergy tests
Roberts
Arch. Dis. Child. 2005;90:564-566.
FULL TEXT  

Drug Metabolism and Variability among Patients in Drug Response
Wilkinson
NEJM 2005;352:2211-2221.
FULL TEXT  

Five Years After To Err Is Human: What Have We Learned?
Leape and Berwick
JAMA 2005;293:2384-2390.
ABSTRACT | FULL TEXT  

The Research on Adverse Drug Events and Reports (RADAR) Project
Bennett et al.
JAMA 2005;293:2131-2140.
ABSTRACT | FULL TEXT  

Concealed Renal Insufficiency and Adverse Drug Reactions in Elderly Hospitalized Patients
Corsonello et al.
Arch Intern Med 2005;165:790-795.
ABSTRACT | FULL TEXT  

Service utilization in 1896 and 1996: morbidity and mortality data from North Wales
Healy et al.
History of Psychiatry 2005;16:27-41.
ABSTRACT  

Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
Corrigan
J. Med. Ethics 2005;31:144-148.
ABSTRACT | FULL TEXT  

Diagnosis and Management of Penicillin Allergy
Park and Li
Mayo Clin Proc. 2005;80:405-410.
ABSTRACT  

Unresolved issues in pharmacy
Zellmer
Am J Health Syst Pharm 2005;62:259-265.
FULL TEXT  

Safety Issues in the Interaction of Conventional, Complementary, and Alternative Health Care
Curtis and Gaylord
Complementary Health Practice Review 2005;10:3-31.
ABSTRACT  

Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche et al.
NEJM 2004;351:2827-2831.
ABSTRACT | FULL TEXT